Multiple cytokines and acute inflammation raise mouse leptin levels: Potential role in inflammatory anorexia

Journal of Experimental Medicine

Volumn 185, Issue 1, 1997, Pages 171-175

  Sarraf, Pasha ^a   Frederich, Robert C ^b   Turner, Ewa M ^a   Ma, Grace ^a   Jaskowiak, Nora T ^a   Rivet III, Dennis J ^a   Flier, Jeffrey S ^b   Lowell, Bradford B ^b   Fraker, Douglas L ^a   Alexander, H Richard ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LEPTIN;

ANIMAL CELL; ANOREXIA; ARTICLE; BASAL METABOLIC RATE; BODY MASS; CACHEXIA; FOOD INTAKE; GENE EXPRESSION REGULATION; INFLAMMATION; MEDIATOR RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; ANOREXIA; CILIARY NEUROTROPHIC FACTOR; CYTOKINES; ESCHERICHIA COLI; FEMALE; GROWTH INHIBITORS; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; INTERLEUKINS; KINETICS; LEPTIN; LEUKEMIA INHIBITORY FACTOR; LIPOPOLYSACCHARIDES; LYMPHOKINES; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; PROTEIN BIOSYNTHESIS; PROTEINS; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 17344384196     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.1.171     Document Type: Article

References (38)

1. Moldawer, L.L., M. Georgieff, and K. Lundholm. 1987. Interleukin 1, tumour necrosis factor-alpha(cachectin) and the pathogenesis of cancer cachexia. Clin. Physiol. 7:263-274.
2. Bendtzen, K. 1988. Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. Immunol. Lett. 19:183-192.
3. Evans, R.D., J.M. Argiles, and D.H. Williamson. 1991. Metabolic effects of tumour necrosis factor-α (cachectin) and inteleukin-1. Clin. Sci. 77:357-364.
4. Mori, M., K. Yamaguchi, S. Honda, K. Nagasaki, M. Ueda, O. Abe, and K. Abe. 1991. Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor. Cancer Res. 51:6656-6659.
5. Jensen, J.C., C.M. Buresh, D.L. Fraker, H.N. Langstein, G.D. Doherty, H.R. Alexander, and J.A. Norton. 1990. Enhanced hepatic cytokine gene expression in cachectic tumor bearing rats. Surg. Forum. 41:469-472.
6. Tracey, K.J., H. Wei, K.R. Manogue, Y. Fong, D.G. Hesse, H.T. Nguyen, G.C. Kuo, B. Beuhler, R.S. Cotran, A. Cerami, and S.F. Lowry. 1988. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J. Exp. Med. 167:1211-1227.
7. Strassman, G., M. Fong, J.S. Kenney, and C.O. Jacob. 1992. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J. Clin. Invest. 89:1681-1684.
8. Socher, S.M., A. Friedman, and D. Martinez. 1988. Recombinant human tumor necrosis factor induces acute reductions in food intake and body weight in mice. J. Exp. Med. 167: 1957-1962.
9. Fraker, D.L., M.C. Stovroff, M.J. Merino, and J.A. Norton. 1988. Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J. Exp. Med. 168:95-105.
10. Metcalf, D. 1991. The leukemia inhibitory factor (LIF). Int. J. Cell Cloning 9:95-108.
11. Butler, L.D., N.K. Layman, R.L. Cain, R.E. Riedl, K.M. Mohler, J.L. Bobbitt, R. Belagajie, J. Sharp, and A.M. Bendele. 1989. Interleukin 1-induced pathophysiology: induction of cytokines, development of histopathologic changes, and immunopharmacologic intervention. Clin. Immunol. Immunopathol. 53:400-421.
12. Oliff, A., D. Defeo-Jones, M. Boyer, D. Martinez, D. Kiefer, G. Vuocolo, A. Wolfe, and S.H. Socher. 1987. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell. 50:555-563.
13. Black, K., I.R. Garrett, and G.R. Mundy. 1991. Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice. Endocrinology. 128:2657-2659.
14. Metcalf, D., and D.P. Gearing. 1989. Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc. Natl. Acad. Sci. USA. 86:5948-5952.
15. Gelin, J., L.L. Moldawer, C. Lonnroth, B. Sherry, R. Chizzonite, and K. Lundholm. 1991. Role of endogenous tumor necrosis factor a and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Cancer Res. 51:415-421.
16. Sherry, B.A. J. Gelin, Y. Fong, M. Marano, H. Wei, A. Cerami, S.F. Lowry, K.G. Lundholm, and L.L. Moldawer. 1989. Anticachectin/tumor necrosis factor-α antibodies attenuate development of cachexia in tumor models. FASEB J. 3:1956-1962.
17. Emilie, D., J. Wijdenes, C. Gisselbrecht, B .Jarrousse, E. Billaud, J.-Y. Blay, J. Gabarre, J.-P. Gaillard, J. Brochier, M. Raphael, F. Boue, and P. Galanaud. 1994. Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: Effect on lymphoma growth and on B clinical symptoms. Blood. 84: 2472-2479.
18. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature (Lond.). 372: 425-432.
19. Flier, J.S. 1995. The Adipocyte: Storage depot or node on the energy information superhighway? Cell. 80:15-18.
20. Frederich, R.C., B. Löllmann, A. Hamann, A. Napolitano-Rosen, B.B. Kahn, B.B. Lowell, and J.S. Flier. 1995. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J. Clin. Invest. 96:1658-1663.
21. Frederich, R.C., A. Hamann, S. Anderson, B. Lollmann, B.B. Lowell, and J.S. Flier. 1995. Leptin levels reflect body lipid content in mice: evidence tor diet-induced resistance to leptin action. Nature Med. 1:1311-1314.
22. Pelleymounter, M.A., M.J. Gullen, M.B. Baker, R. Hecht, D. Winters, T. Boone, and F. Collins. 1995. Effects of the obese gene product on body weight regulation in ob/ob mice. Science (Wash. DC). 269:540-543.
23. Halaas, J.L., K.S. Gajiwala, M. Maffei, S.L. Cohen, B.T. Chait, D. Rabinowitz, R.L. Lallone, S.K. Burley, and J.M. Friedman. 1995. Weight-reducing effects of the plasma protein encoded by the obese gene. Science (wash. DC). 269: 543-546.
24. Campfield, L.A., F.J. Smith, Y. Guisez, R. Devos, and P. Burn. 1995. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science (Wash. DC). 269:546-549.
25. Saladin, R., P. De Vos, M. Guerve-Millo, A. Leturque, J. Girard, B. Staels, and J. Auwerx. 1995. Transient increase in obese-gene expression after food intake or insulin administration. Nature (Lond.). 377:527-529.
26. Nelson, W., L. Scheving, and F. Halberg. 1995. Circadian rhythms in mice fed a single daily meal at different stages of lighting regimen. J. Nutr. 105:171-184.
27. McNamara, M.J., H.R. Alexander, and J.A. Norton. 1992. Cytokines and their role in the pathophysiology of cancer cachexia. J. Parenter. Enteral Nutr. 16:505-535.
28. Jablons, D.M., J.K. McIntosh, and J.J. Mulé. 1989. Induction of interferon-2/interleukin-6 by cytokine administration and detection of circulating interleukin-6 in the tumor bearing state. Ann. NY Acad. Sci. 557:157-160.
29. Kishimoto, T., S. Akira, and T. Taga. 1992. Interleukin-6 and its receptor: a paradigm for cytokines. Science (Wash. DC). 258:593-597.
30. Truitt, R.L., C.A. Keever, and E.C. Borden. 1995. Role of IL-4, IL-6, and IL-12 in cancer therapy. In Biologic Therapy of Cancer. V.T. DeVita, S. Hellman, and S.A. Rosenberg, editors. J.B. Lippincott, Philadelphia. 279-293.
31. Bogdan, C., and C. Nathan. 1993. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann. NY Acad. Sci. 685:713-739.
32. deWaal Malefyt, R., H. Yssel, M.-G. Roncarolo, H. Spits, and J.E. deVries. 1992. Interleukin-10. Curr. Opin. Immunol. 4:314-320.
33. Bogdan, C., Y. Vodovotz, and C. Nathan. 1991. Macrophage deactivation by interleukin 10. J. Exp. Med. 174:1549-1555.
34. Collins, S., C.M. Kuhn, A.E. Petro, A.C. Swick, B.A. Chrunyk, and R.S. Surwit. 1996. Role of leptin in fat regulation. Nature (Lond.). 380:677.
35. Chehab, P.F., M.E. Lim, and R. Lu. 1996. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nature Genet. 12: 318-320.
36. Tartaglia, L.A., M. Dembski, X. Weng, N. Deng, J. Culpepper, R. Devos, G.J. Richards, L.A. Campfield, F.T. Clark, J. Deeds et al. 1995. Identification and expression cloning of a leptin receptor, OB-R. Cell. 83:1263-1271.
37. Cioffi, J.A., A.W. Shafer, T.J. Zupancic, J. Smith-Gbur, A. Mikhail, D. Platika, and H.R. Snodgrass. 1996. Novel B219/ OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction. Nature Med. 2:585-589.
38. Grunfeld, C., C. Zhao, J. Fuller, A. Pollock, A. Moser, J. Friedman, and K.R. Feingold. 1996. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J. Clin. Invest. 97:2152-2157.